SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050566
Filing Date
2020-11-04
Accepted
2020-11-04 17:04:04
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20200930.htm   iXBRL 10-Q 2201960
2 EX-10.1 acad-ex101_114.htm EX-10.1 46481
3 EX-31.1 acad-ex311_7.htm EX-31.1 9477
4 EX-31.2 acad-ex312_9.htm EX-31.2 9218
5 EX-32.1 acad-ex321_8.htm EX-32.1 6339
6 EX-32.2 acad-ex322_6.htm EX-32.2 6394
  Complete submission text file 0001564590-20-050566.txt   7405374

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20200930.xsd EX-101.SCH 41329
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20200930_cal.xml EX-101.CAL 56632
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20200930_def.xml EX-101.DEF 98141
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200930_lab.xml EX-101.LAB 306793
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200930_pre.xml EX-101.PRE 234976
12 EXTRACTED XBRL INSTANCE DOCUMENT acad-10q_20200930_htm.xml XML 1476596
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 201287475
SIC: 2834 Pharmaceutical Preparations